Neoplasie ematologiche (linfomi, LLC, mieloma, macrogloublinemia di Waldenstrom, leucemia acuta)
Arca
Contatti

Luca Arcaini, PI

Email: luca.arcaini@unipv.it

Componenti
Attività di ricerca

Clinical and translational research in hematological malignancies (lymphoma. CLL, WM, myeloma, acute leukemia).

Bibliografia

 

Luminari S, Merli M, Rattotti S, Tarantino V, Marcheselli L, Cavallo F, Varettoni M, Bianchi B, Merli F, Tedeschi A, Cabras G, Re F, Visco C, Delamain MT, Cencini E, Spina M, Ferrero S, Ferrari A, Deodato M, Mannina D, Annibali O, Rago A, Orsucci L, Defrancesco I, Frigeni M, Cesaretti M, Arcaini L Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study Blood 134(10):798-801, 2019

Defrancesco I, Visentini M, Zibellini S, Minafò YA, Rattotti S, Ferretti VV, Rizzo E, Varettoni M, Frigeni M, Pulsoni A, Casato A, Colantuono S, Rossi M, Candido C, Zerbi C, Bergamini F, Cristinelli C, Fabbri N, Merli M, Zuccaro V, Bruno R, Paulli M, Arcaini L Mutational landscape of HCV-associated B-cell lymphoproliferative disorders American Journal of Hematology 96(6):E210-E214, 2021

Varettoni M, Orlandi E, Zibellini S, Rossi M, Gentile M, Flospergher E, Ferretti VV, Rizzo E, Della Porta MG, Rattotti S, Cavalloni C, Bergamini F, Cristinelli C, Fabbri N, Gallì A, Arcaini L. Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia. Am J Hematol. 2021 Nov 1;96(11):E404-E408.

Rossi M, Nizzoli ME, Gallì A, Roncoroni E, Zibellini S, Merati G, Rizzo E, Rocca B, Pietra D, Picone C, Brociner M, Tobar Cabrera CP, Gelli E, Santacroce E, Arcaini L, Zappasodi P. Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome. Am J Hematol. 2022 Apr;97(4):E135-E138.

Merli M, Rattotti S, Spina M, Re F, Motta M, Piazza F, Orsucci L, Ferreri AJM, Perbellini O, Dodero A, Vallisa D, Pulsoni A, Santoro A, Sacchi P, Zuccaro V, Chimienti E, Russo F, Visco C, Zignego AL, Marcheselli L, Passamonti F, Luminari S, Paulli M, Bruno R, Arcaini L.on behalf of Fondazione Italiana Linfomi Direct-Acting Antivirals as Primary Treatment for Hepatitis C virus-Associated Indolent Non- Hodgkin’s Lymphomas: the BArT Study of the Fondazione Italiana Linfomi Journal of Clinical Oncology 2022